Suchergebnisse - "4Z8R6ORS6L"

PubPharm (9.895)

1

Thalidomide for management of refractory oral mucosal diseases

enthalten in: Oral surgery, oral medicine, oral pathology and oral radiology | 2024

von Xu, Y. | Woo, S. | Treister, N.

2

Harnessing the potential of fatty Acid-Surfactant-Based micellar gel for enhanced topical delivery of Apremilast in psoriasis treatment

enthalten in: International journal of pharmaceutics | 2024

von Sontakke, A. | Dighe, S. | Sharma, R. | +2

3

Jian Y, Chang L, Shi M-X, et al. Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment. Blood Adv. 2023;7(24):7581-7584

enthalten in: Blood advances | 2024

ErratumFor: Blood Adv. 2023 Dec 26;7(24):7581-7584. - PMID 37922425

4

Extramedullary relapse of multiple myeloma presenting as space-occupying lesion in liver treated with daratumumab, pomalidomide, dexamethasone and bendamustine

enthalten in: BMJ case reports | 2024

von Wadhera, S. | Jain, A. | Mitra, S. | +1

5

Anti-inflammatory effect of thalidomide in an experimental lung donor model of brain death

enthalten in: Scientific reports | 2024

von Sana Vilela, V. | Andrighetti de Oliveira Braga, K. | Moreira Ruiz, L. | +7

6

Discovery and characterization of potent spiro-isoxazole-based cereblon ligands with a novel binding mode

enthalten in: European journal of medicinal chemistry | 2024

von Shevalev, R. | Bischof, L. | Sapegin, A. | +5

7

Chronic type 2 reaction in lepromatous leprosy with underlying Plasmodium falciparum infection : A case report

enthalten in: Tropical doctor | 2024

von Sagar, H. | Pawar, H.

8

Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and Spain

enthalten in: European journal of haematology | 2024

von Lehne, M. | Kortüm, K. | Ramasamy, K. | +10

9

A Phase II Study to Evaluate the Efficacy of Bortezomib in Combination with Thalidomide in Treatment-Naïve Waldenstrom Macroglobulinemia Patients

enthalten in: Cancer research and treatment | 2024

von Byun, J. | Shin, J. | Kim, S. | +9

10

Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens : patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial

enthalten in: The Lancet. Haematology | 2024

von Delforge, M. | Patel, K. | Eliason, L. | +15

ErratumIn: Lancet Haematol. 2024 Mar 12;:. - PMID 38490233

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[990]